Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$24,046,489
+$79,098 QoQ
Shares Held
153,436
-2.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.28%
of 13F equity value
Holder Rank
#105
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GRANDFIELD & DODD, LLC holds $118,444,709 across 12 Drug Manufacturers - General names. NVS ranks #2 (20.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
106,768 | $27,115,868 | |
| 2 | NVS |
Novartis AG
This page
|
153,436 | $24,046,489 | |
| 3 | MRK |
Merck & Co., Inc.
|
171,554 | $22,044,689 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
154,287 | $19,492,619 | |
| 5 | SNY |
Sanofi
|
384,643 | $16,408,870 | |
| 6 | AMGN |
Amgen Inc
|
7,491 | $2,712,640 | |
| 7 | LLY |
ELI LILLY & Co
|
2,035 | $2,440,840 | |
| 8 | ABBV |
AbbVie Inc.
|
5,744 | $1,445,420 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,046,489 | 153,436 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $23,967,391 | 156,906 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $21,417,828 | 155,348 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $20,879,780 | 162,818 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $19,640,770 | 162,307 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $18,196,323 | 163,225 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $15,927,214 | 163,675 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $18,674,992 | 162,363 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $17,091,301 | 160,542 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $15,453,971 | 159,764 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $15,956,390 | 158,031 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $15,790,948 | 155,026 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $15,515,618 | 153,757 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $14,131,292 | 153,601 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $13,795,155 | 152,063 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $10,580,820 | 139,203 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $11,620,254 | 137,469 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $11,764,203 | 134,065 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $11,334,799 | 129,585 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $10,275,248 | 125,645 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $12,129,354 | 132,939 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $11,036,750 | 129,115 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $12,400,358 | 131,318 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $11,469,850 | 131,898 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $11,321,709 | 129,628 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $10,637,946 | 129,023 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||